Traws Pharma, Inc. Basic Shares Outstanding (Weighted Average)
Traws Pharma, Inc. (TRAW) reported Basic Shares Outstanding (Weighted Average) of 15.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 15.86M shares, a 172.54% increase year-over-year.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.64M shares, a 52.75% increase year-over-year.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.36M shares, a 203.89% increase year-over-year.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 8.82M shares, a 817.17% increase year-over-year.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 8.23M shares, a 429.93% increase from fiscal 2024.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.55M shares, a 84.94% increase from fiscal 2023.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 839.55K shares, a 95.98% decline from fiscal 2022.
- Traws Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 20.91M shares, a 24.22% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.86M shares 10-Q · filed 2026-08-14 | 13.27M shares 10-Q · filed 2026-08-14 | 11.95M shares derived: average of 3 quarters · filed 2026-08-14 | 11.17M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 10.64M shares 10-Q · filed 2026-05-15 | 10.00M shares derived: average of 2 quarters · filed 2026-05-15 | 9.61M shares derived: average of 3 quarters · filed 2026-05-15 | 8.66M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 9.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 9.09M shares derived: average of 2 quarters · filed 2026-04-15 | 8.00M shares derived: average of 3 quarters · filed 2026-08-14 | 8.23M shares 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | 8.82M shares 10-Q · filed 2025-11-13 | 7.32M shares derived: average of 2 quarters · filed 2026-08-14 | 7.85M shares 10-Q · filed 2025-11-13 | 6.17M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 5.82M shares 10-Q · filed 2026-08-14 | 7.36M shares 10-Q · filed 2026-08-14 | 5.29M shares derived: average of 3 quarters · filed 2026-08-14 | 4.21M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 6.97M shares 10-Q · filed 2026-05-15 | 5.02M shares derived: average of 2 quarters · filed 2026-05-15 | 3.67M shares derived: average of 3 quarters · filed 2026-05-15 | 3.00M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 3.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 2.02M shares derived: average of 2 quarters · filed 2026-04-15 | 1.68M shares derived: average of 3 quarters · filed 2026-04-15 | 1.55M shares 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | 961.53K shares 10-Q · filed 2025-11-13 | 986.98K shares derived: average of 2 quarters · filed 2025-11-13 | 1.04M shares 10-Q · filed 2025-11-13 | 914.05K shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 1.01M shares 10-Q · filed 2025-08-14 | 25.31M shares 10-Q · filed 2024-08-15 | 927.08K shares 10-Q · filed 2025-08-14 | 23.18M shares 10-Q · filed 2024-08-15 | 898.22K shares derived: average of 3 quarters · filed 2025-08-14 | 883.69K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 841.74K shares 10-Q · filed 2025-05-15 | 21.04M shares 10-Q · filed 2024-05-15 | 841.11K shares derived: average of 2 quarters · filed 2025-05-15 | 840.78K shares derived: average of 3 quarters · filed 2025-05-15 | 5.88M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 840.49K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 840.30K shares derived: average of 2 quarters · filed 2025-03-31 | 7.55M shares derived: average of 3 quarters · filed 2025-03-31 | 839.55K shares 10-K · filed 2025-03-31 | 20.99M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 840.12K shares 10-Q · filed 2024-11-14 | 21.00M shares 10-Q · filed 2023-11-14 | 10.91M shares derived: average of 2 quarters · filed 2024-11-14 | 839.24K shares 10-Q · filed 2024-11-14 | 20.98M shares 10-Q · filed 2023-11-14 | 15.93M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 20.98M shares 10-Q · filed 2024-08-15 | 20.97M shares 10-Q · filed 2024-08-15 | 20.96M shares derived: average of 3 quarters · filed 2024-08-15 | 20.95M shares derived: average of 4 quarters · filed 2024-08-15 | ||||
| 2023-03-31 | 20.96M shares 10-Q · filed 2024-05-15 | 20.94M shares derived: average of 2 quarters · filed 2024-05-15 | 20.93M shares derived: average of 3 quarters · filed 2024-05-15 | 20.93M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 20.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 20.92M shares derived: average of 2 quarters · filed 2024-04-01 | 20.92M shares derived: average of 3 quarters · filed 2024-04-01 | 20.91M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 20.92M shares 10-Q · filed 2023-11-14 | 20.91M shares derived: average of 2 quarters · filed 2023-11-14 | 20.90M shares 10-Q · filed 2023-11-14 | 20.92M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 20.90M shares 10-Q · filed 2023-08-14 | 20.90M shares 10-Q · filed 2023-08-14 | 20.92M shares derived: average of 3 quarters · filed 2023-08-14 | 19.68M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 20.90M shares 10-Q · filed 2023-05-15 | 20.92M shares derived: average of 2 quarters · filed 2023-05-15 | 19.27M shares derived: average of 3 quarters · filed 2023-05-15 | 18.40M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 20.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 18.46M shares derived: average of 2 quarters · filed 2023-03-30 | 17.57M shares derived: average of 3 quarters · filed 2023-03-30 | 16.83M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 15.98M shares 10-Q · filed 2022-11-14 | 15.88M shares derived: average of 2 quarters · filed 2022-11-14 | 15.46M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 15.78M shares 10-Q · filed 2022-08-15 | 15.20M shares 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 14.62M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 11.60M shares 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |